Finasteride-its impact on sexual function and prostate cancer
Finasteride, a specific and competitive inhibitor of 5a-reductase enzyme Type 2, inhibits the conversion of testosterone to dihydrotestosterone (DHT). In adults, DHT acts as primary androgen in prostate and hair follicles. The only FDA-approved dermatological indication of finasteride is androgeneti...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2009-01-01
|
| Series: | Journal of Cutaneous and Aesthetic Surgery |
| Subjects: | |
| Online Access: | http://www.jcasonline.com/article.asp?issn=0974-2077;year=2009;volume=2;issue=1;spage=12;epage=16;aulast=Anitha |